{"name": "cCAM Biotherapeutics",
 "permalink": "ccam-biotherapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/ccam-biotherapeutics",
 "homepage_url": "http://ccam-bio.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@ccam-bio.com",
 "phone_number": "972-4-6818829",
 "description": "",
 "created_at": "Sat Sep 15 05:14:14 UTC 2012",
 "updated_at": "Sat Sep 15 05:19:05 UTC 2012",
 "overview": "\u003Cp\u003EcCAM Biotherapeutics is a pre-clinical stage company developing immunotherapies for cancer. cCAM\u0026#8217;s lead agent, CM-10, is an immunomodulatory antibody that harnesses the patient\u0026#8217;s immune system to attack tumors. CM-10 binds CEACAM1, a protein used by cancer cells to suppress the immune system. CM-10 abrogates this effect, leading to a cancer specific immune response in patients.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       110],
      "assets/images/resized/0021/1445/211445v1-max-150x150.jpg"],
     [[189,
       139],
      "assets/images/resized/0021/1445/211445v1-max-250x250.jpg"],
     [[189,
       139],
      "assets/images/resized/0021/1445/211445v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://finance.yahoo.com/news/ccam-biotherapeutics-announced-today-completion-100200778.html",
    "source_description": "cCAM Biotherapeutics Announced Today the Completion of its Series A Financing",
    "raised_amount": null,
    "raised_currency_code": null,
    "funded_year": 2012,
    "funded_month": 9,
    "funded_day": 15,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Arkin Holdings",
         "permalink": "arkin-holdings",
         "image":
          {"available_sizes":
            [[[150,
               72],
              "assets/images/resized/0021/1448/211448v1-max-150x150.jpg"],
             [[193,
               93],
              "assets/images/resized/0021/1448/211448v1-max-250x250.jpg"],
             [[193,
               93],
              "assets/images/resized/0021/1448/211448v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Israel Partners",
         "permalink": "israel-partners",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Pontifax",
         "permalink": "pontifax",
         "image": null},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Tel-Hai Industrial Park",
    "address2": "POB 408 Kiryat-Shmona 11013",
    "zip_code": "",
    "city": "",
    "state_code": null,
    "country_code": "ISR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        100],
       "assets/images/resized/0021/1446/211446v1-max-150x150.jpg"],
      [[250,
        168],
       "assets/images/resized/0021/1446/211446v1-max-250x250.jpg"],
      [[450,
        302],
       "assets/images/resized/0021/1446/211446v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}